Recent Comments

Comment RSS

Folic Acid News and Research RSS Feed - Folic Acid News and Research

Folic acid is a B vitamin. It helps the body make healthy new cells. Everyone needs folic acid. For women who may get pregnant, it is really important. When a woman has enough folic acid in her body before and during pregnancy, it can prevent major birth defects of her baby's brain or spine.

Foods with folic acid in them include leafy green vegetables, fruits, dried beans, peas and nuts. Enriched breads, cereals and other grain products also contain folic acid. If you don't get enough folic acid from the foods you eat, you can also take it as a dietary supplement.

Study examines link between folic acid and cancer incidence

18. November 2009 03:40
Patients with heart disease in Norway, a country with no fortification of foods with folic acid, had an associated increased risk of cancer and death from any cause if they had received treatment with folic acid and vitamin B12, according to a study in the November 18 issue of JAMA. [More]

Spectrum Pharmaceuticals reports consolidated revenues of $7.1M for the third quarter of 2009

12. November 2009 07:57
Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the third quarter ended September 30, 2009. [More]

Updated efficacy results from Allos Therapeutics' FOLOTYN study to be presented at the ASH meeting

12. November 2009 03:40
Allos Therapeutics, Inc. today announced that abstracts from studies of FOLOTYN™ (pralatrexate injection) were accepted for presentation at the 51st Annual Meeting of the American Society of Hematology (ASH) to be held at the Ernest N. Morial Convention Center in New Orleans, La., from December 5-8, 2009. [More]

Study sheds light on the rise in childhood asthma in developed countries

4. November 2009 01:27
A University of Adelaide study may have shed light on the rise in childhood asthma in developed countries like Australia in recent decades. [More]

Posted in: Child Health News | Medical Condition News

Tags: , , ,

Iron-folic acid supplements during pregnancy can reduce offspring’s mortality rate

29. October 2009 01:50
Offspring whose mothers had been supplemented with iron-folic acid during pregnancy had dramatically reduced mortality through age 7, according to researchers at the Johns Hopkins Bloomberg School of Public Health. [More]

Posted in: Child Health News | Pharmaceutical News

Tags: , , , , , ,

Study links low maternal folate levels with attention-deficit/hyperactivity problems in children

29. October 2009 00:59
It has long been suggested that healthy folate (the natural form of folic acid) levels in expectant mothers goes hand in hand with healthy nervous system development in their children. A study published in an upcoming issue of the Journal of Child Psychology and Psychiatry finds that low maternal folate levels is linked to the development of attention-deficit/hyperactivity problems in children at age seven to nine years. [More]

Posted in: Child Health News | Women's Health News

Tags: , , , , , , ,

Blocking folic acid action during early pregnancy leads to increased risk of abnormalities in growing baby

15. October 2009 00:06
Using medication that reduces or blocks the actions of folic acid during the first trimester of pregnancy (weeks 1-12), increases the risk that the growing baby will develop abnormalities. This conclusion was reached by a team of Epidemiologists, Paediatricians, Clinical Pharmacologists, Obstetricians and Gynaecologists who examined birth and abortion data collected in Israel between 1998 and 2007. [More]

Medications to reduce folic acid during pregnancy increase the risk of abnormalities in fetus

14. October 2009 23:50
Pregnant women are advised to take vitamin supplements containing folic acid as part of their routine pre-natal care. Now, a new study warns that taking medications that reduce or block the actions of folic acid during the first trimester of pregnancy increase the risk that the growing baby will develop abnormalities. [More]

Spectrum Pharmaceuticals receives Complete Response letter from the FDA for FUSILEV

13. October 2009 01:34
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for injection for treatment of patients with advanced metastatic colorectal cancer. [More]

Inflammation markers not involved with the chemopreventative effect of aspirin on colorectal adenomas

13. October 2009 01:10
Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , ,

Rice consumption improves overall diet and reduces obesity and Type II diabetes

12. October 2009 08:48
According to recent research published in the October issue of the Journal of the American Dietetic Association (JADA), eating rice helps improve overall diet and potentially reduces the risk for many chronic diseases, including obesity, cardiovascular disease and Type II diabetes. [More]

Posted in: Medical Condition News

Tags: , , , , , , , ,

B-vitamin supplements do not prevent heart attack

7. October 2009 01:32
B-vitamin supplements should not be recommended for prevention of heart disease, say scientists. A Cochrane Systematic Review has shown these supplements do not reduce the risk of developing or dying from the disease. [More]

Posted in: Medical Condition News | Miscellaneous News

Tags: , , ,

FOLOTYN available for commercial sale in the United States

6. October 2009 00:11
Allos Therapeutics, Inc. today announced that FOLOTYN (pralatrexate injection) is now available for commercial sale in the United States. The U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYN for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) on September 24, 2009. This indication is based on overall response rate. [More]

Posted in: Pharmaceutical News

Tags: , , , , , , , , , , , , ,

FDA grants accelerated approval for Allos Therapeutics’ FOLOTYN

28. September 2009 03:42
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). [More]

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

21. September 2009 08:10
Data published today in The Lancet showed a survival benefit in nonsquamous patients with advanced non-small cell lung cancer (NSCLC) who received maintenance therapy with ALIMTA(R) (pemetrexed for injection) plus best supportive care as compared to placebo plus best supportive care. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.